Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 26

Results For "biologic"

1133 News Found

Shreehas Tambe appointed as new chairman of CII's National Pharmaceutical Committee
People | June 06, 2026

Shreehas Tambe appointed as new chairman of CII's National Pharmaceutical Committee

Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term


Lupin secures U.S. FDA approval for interchangeable biosimilar Ranibizumab
Drug Approval | June 06, 2026

Lupin secures U.S. FDA approval for interchangeable biosimilar Ranibizumab

Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations


Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment
Biopharma | June 05, 2026

Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment

Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe


CII appoints Manni Kantipudi and Manoj Kumar R. Panicker to lead CRDMO task force
People | June 04, 2026

CII appoints Manni Kantipudi and Manoj Kumar R. Panicker to lead CRDMO task force

Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector


Ipca Laboratories appoints Dr. Sandarbh Rishi as Head – MSAT/Pilot Plant
People | June 04, 2026

Ipca Laboratories appoints Dr. Sandarbh Rishi as Head – MSAT/Pilot Plant

Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations


Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes
R&D | June 02, 2026

Scientists develop rapid nanosensor to detect gut health biomarker for IBD and diabetes

Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices


Aragen scales Renaissance Pharma’s cancer antibody to commercial GMP in just 9 months
Biopharma | June 02, 2026

Aragen scales Renaissance Pharma’s cancer antibody to commercial GMP in just 9 months

Anti-GD2 monoclonal antibody for high-risk neuroblastoma advances toward BLA submission following successful tech transfer from California to Bengaluru


Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm
Opinion | June 01, 2026

Insect biotech as India's next deeptech opportunity: Ankit Alok Bagaria, Co-founder and CEO, Loopworm

We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms


International scientists say deuterium research could reshape medicine
R&D | June 01, 2026

International scientists say deuterium research could reshape medicine

The conference highlighted research suggesting that deuterium levels may influence key biological processes


Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections
Drug Approval | June 01, 2026

Wockhardt wins FDA nod for new antibiotic ZAYNICH against drug-resistant infections

The approval marks a major milestone in the global fight against antimicrobial resistance